See more : TCW Special Purpose Acquisition Corp. (TSPQ-UN) Income Statement Analysis – Financial Results
Complete financial analysis of Harvest Health & Recreation Inc. (HRVSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harvest Health & Recreation Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Guoanda Co., Ltd. (300902.SZ) Income Statement Analysis – Financial Results
- Productivity Technologies Corp. (PRAC) Income Statement Analysis – Financial Results
- Apollo Tyres Limited (APOLLOTYRE.BO) Income Statement Analysis – Financial Results
- Hollywood Intermediate, Inc. (HYWI) Income Statement Analysis – Financial Results
- MRS Logística S.A. (MRSA5B.SA) Income Statement Analysis – Financial Results
Harvest Health & Recreation Inc. (HRVSF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.harvesthoc.com
About Harvest Health & Recreation Inc.
Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 231.46M | 116.78M | 77.79K | 200.29K | 284.45K | 482.02K | 675.22K | 368.83K | 292.64K | 233.88K | 180.62K | 147.97K | 24.10K |
| Cost of Revenue | 129.87M | 73.21M | 15.89K | 56.47K | 31.73K | 94.81K | 160.79K | 51.74K | 269.58K | 478.39K | 372.72K | 1.23M | 14.92K |
| Gross Profit | 101.59M | 43.57M | 61.91K | 143.82K | 252.72K | 387.20K | 514.43K | 317.09K | 23.05K | -244.51K | -192.10K | -1.08M | 9.18K |
| Gross Profit Ratio | 43.89% | 37.31% | 79.58% | 71.81% | 88.84% | 80.33% | 76.19% | 85.97% | 7.88% | -104.55% | -106.36% | -728.50% | 38.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.10M | 115.86M | 83.35K | 65.96K | 78.32K | 129.18K | 251.07K | 246.79K | 446.60K | 505.30K | 498.98K | 498.25K | 0.00 |
| Selling & Marketing | 4.96M | 8.94M | 0.00 | 0.00 | 0.00 | 0.00 | 1.40K | 0.00 | 1.26K | 0.00 | 10.93K | 0.00 | 0.00 |
| SG&A | 127.06M | 124.80M | 83.35K | 65.96K | 78.32K | 129.18K | 252.46K | 246.79K | 447.86K | 505.30K | 509.91K | 498.25K | 0.00 |
| Other Expenses | 7.92M | 10.30M | 93.75K | 126.55K | 300.84K | 408.79K | 308.00K | 180.03K | 55.80K | 0.00 | 0.00 | 0.00 | 1.46M |
| Operating Expenses | 134.98M | 135.10M | 177.10K | 192.51K | 379.15K | 537.97K | 560.47K | 426.82K | 503.65K | 505.30K | 509.91K | 498.25K | 1.46M |
| Cost & Expenses | 264.85M | 208.30M | 192.98K | 248.98K | 410.89K | 632.79K | 721.26K | 478.56K | 773.24K | 983.69K | 882.64K | 1.72M | 1.48M |
| Interest Income | 444.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.03 | 615.56 | 568.96 | 1.21K | 1.98K | 9.68K | 1.53K |
| Interest Expense | 39.06M | 16.24M | 4.78K | 5.50K | 3.34K | 5.27K | 6.99K | 10.34K | 32.61K | 27.68K | 16.64K | 2.28K | 0.00 |
| Depreciation & Amortization | 16.67M | 12.69M | 2.93K | 5.22K | 3.29K | 13.51K | 24.44K | 6.09K | 55.80K | 200.11K | 165.86K | 991.47K | 651.57K |
| EBITDA | -259.00K | -140.80M | -347.62K | -43.47K | -109.40K | -110.67K | -219.74K | -125.25K | -25.86K | -645.52K | -1.56M | -575.04K | -801.24K |
| EBITDA Ratio | -0.11% | -120.57% | -446.85% | -21.71% | -38.46% | -22.96% | -32.54% | -33.96% | -8.84% | -276.01% | -866.36% | -388.63% | -3,324.16% |
| Operating Income | -33.39M | -91.52M | -115.19K | -48.69K | -126.44K | -150.77K | -46.04K | -109.73K | -480.60K | -749.81K | -702.02K | -1.58M | -1.45M |
| Operating Income Ratio | -14.43% | -78.37% | -148.07% | -24.31% | -44.45% | -31.28% | -6.82% | -29.75% | -164.23% | -320.60% | -388.67% | -1,065.22% | -6,033.34% |
| Total Other Income/Expenses | -21.26M | -80.29M | -240.14K | -5.50K | 10.40K | 21.32K | -205.13K | -31.96K | 366.34K | -97.03K | -933.72K | 0.00 | 0.00 |
| Income Before Tax | -54.65M | -171.81M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -846.84K | -1.64M | 0.00 | 0.00 |
| Income Before Tax Ratio | -23.61% | -147.12% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -362.08% | -905.63% | 0.00% | 0.00% |
| Income Tax Expense | 3.65M | 3.76M | -235.36K | 0.00 | 13.75K | 26.59K | -198.14K | -21.61K | 398.95K | -69.35K | -917.09K | 2.28K | 0.00 |
| Net Income | -59.63M | -173.49M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -873.31K | -1.75M | -1.57M | -1.45M |
| Net Income Ratio | -25.76% | -148.56% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -373.40% | -967.40% | -1,060.22% | -6,027.36% |
| EPS | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
| EPS Diluted | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
| Weighted Avg Shares Out | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
| Weighted Avg Shares Out (Dil) | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
Trulieve Opens Four More Cannabis Dispensaries In Florida, Leveraging Harvest Health & Recreation Acquisition
Cannabis retailer Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) continues to build on its store opening streak in Florida. Based in Tallahassee, the company said Wednesday it is reopening four dispensaries formerly branded as Harvest House of Cannabis in Jacksonville, Gainesville, Kissimmee and...
Trulieve Completes $350M Private Placement To Repay Harvest Health's Debt
Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) reported Wednesday it has completed its previously announced private placement of 8% senior secured notes due 2026 for aggregate gross proceeds of $350 million. The notes, issued at 100% of face value, are senior secured obligations of...
Trulieve shares rise as it closes its Harvest Health acquisition
Trulieve Cannabis Corp. TCNNF, +3.38% shares rose 3.4% on Friday after the company closed its acquisition of Harvest Health & Recreation by issuing 50.87 million shares. With combined second-quarter revenue of $317.6 million, Trulieve ranks among the highest among U.S....
Planet 13 Enters Florida Medical Marijuana Market Via $55M Purchase Of Harvest Health's License
Vertically integrated cannabis company Planet 13 Holdings Inc. (CSE:PLTH) (OTCQX:PLNHF) has completed its previously announced purchase of a license issued by the Florida Department of Health to operate as a Medical Marijuana Treatment Center in the Sunshine State. Based in Las...
Billion Dollar Trulieve-Harvest Merger Closes, Combined Co. To Hit $1.2B In 2021 Revenue
Trulieve Cannabis Corp (CSE:TRUL) (OTCQX:TCNNF) and Harvest Health & Recreation Inc. (CSE:HARV) (OTCQX:HRVSF) have wrapped up their previously announced billion-dollar merger after months of negotiations. The move comes on Trulieve's announcement that it has secured $350 million in financing through a private...
Trulieve Borrows $350M To Repay Harvest Health's Debt, Expands Partnership With Bhang
Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) announced Thursday it has obtained commitments for a private placement of 8% senior secured notes due 2026 for aggregate gross proceeds of $350.0 million. Canaccord Genuity Corp. will act as sole agent and sole bookrunner.
2 Marijuana Stocks To Watch As The House Votes On Federal Cannabis Reform
2 Marijuana Stocks To Watch For More Trading Momentum In 2021 The post 2 Marijuana Stocks To Watch As The House Votes On Federal Cannabis Reform appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding...
2 Marijuana Stocks To Watch Heading Into October
Top Marijuana Stocks For Next Weeks Watchlist The post 2 Marijuana Stocks To Watch Heading Into October appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Hot Marijuana Penny Stocks To Watch Right Now
Penny Stocks To Watch In September 2021 The post Hot Marijuana Penny Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Is Trulieve Still A Top Pick Ahead of $2B Harvest Health Merger?
Over the past year, Trulieve Cannabis Corp. (CSE:TRUL) (OTC:TCNNF) has significantly expanded its nationwide footprint, as evidenced by its recent milestone of opening its 99th and 100th cannabis dispensaries. And, apart from being the leading medical cannabis company in the state...
Source: https://incomestatements.info
Category: Stock Reports